DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,074 filers reported holding DANAHER CORPORATION in Q4 2022. The put-call ratio across all filers is 1.10 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $13,152 | -22.0% | 53,009 | -24.5% | 0.15% | +18.1% |
| Q2 2023 | $16,857 | +1.7% | 70,239 | +6.8% | 0.13% | -34.2% |
| Q1 2023 | $16,583 | -51.9% | 65,797 | -49.3% | 0.19% | -54.0% |
| Q4 2022 | $34,471 | -99.9% | 129,874 | +37.3% | 0.42% | +39.1% |
| Q3 2022 | $24,432,000 | +491.1% | 94,591 | +480.2% | 0.30% | +586.4% |
| Q2 2022 | $4,133,000 | -58.6% | 16,303 | -52.1% | 0.04% | -39.7% |
| Q1 2022 | $9,976,000 | +20.9% | 34,011 | +35.6% | 0.07% | +62.2% |
| Q4 2021 | $8,250,000 | -87.5% | 25,076 | -88.5% | 0.04% | -85.5% |
| Q3 2021 | $66,132,000 | +2186.7% | 217,224 | +1916.0% | 0.31% | +2284.6% |
| Q2 2021 | $2,892,000 | -97.7% | 10,775 | -98.0% | 0.01% | -98.0% |
| Q1 2021 | $123,106,000 | +114.9% | 546,943 | +112.1% | 0.64% | +110.8% |
| Q4 2020 | $57,292,000 | +4276.8% | 257,911 | +4141.3% | 0.31% | +3725.0% |
| Q3 2020 | $1,309,000 | -62.0% | 6,081 | -68.8% | 0.01% | -72.4% |
| Q2 2020 | $3,448,000 | -58.4% | 19,499 | -67.5% | 0.03% | -62.8% |
| Q1 2020 | $8,292,000 | -84.7% | 59,907 | -83.0% | 0.08% | -84.2% |
| Q4 2019 | $54,076,000 | -33.3% | 352,335 | -37.2% | 0.49% | -25.9% |
| Q3 2019 | $81,093,000 | +182.2% | 561,470 | +179.3% | 0.66% | +235.9% |
| Q2 2019 | $28,733,000 | +119.5% | 201,043 | +102.7% | 0.20% | +63.6% |
| Q1 2019 | $13,093,000 | -59.8% | 99,176 | -68.6% | 0.12% | -57.5% |
| Q4 2018 | $32,562,000 | +55.9% | 315,769 | +64.3% | 0.28% | +83.9% |
| Q3 2018 | $20,881,000 | -18.8% | 192,169 | -26.3% | 0.16% | -33.2% |
| Q2 2018 | $25,731,000 | +118.8% | 260,750 | +117.1% | 0.23% | +146.8% |
| Q1 2018 | $11,760,000 | +55.1% | 120,107 | +47.0% | 0.09% | +32.4% |
| Q4 2017 | $7,583,000 | +276.9% | 81,696 | +248.3% | 0.07% | +294.4% |
| Q3 2017 | $2,012,000 | -67.6% | 23,454 | -68.1% | 0.02% | -67.9% |
| Q2 2017 | $6,201,000 | -40.4% | 73,480 | -39.6% | 0.06% | -39.1% |
| Q1 2017 | $10,401,000 | -5.6% | 121,605 | -14.1% | 0.09% | 0.0% |
| Q4 2016 | $11,017,000 | +1517.8% | 141,540 | +1528.8% | 0.09% | +1214.3% |
| Q3 2016 | $681,000 | -97.5% | 8,690 | -96.7% | 0.01% | -96.3% |
| Q2 2016 | $26,829,000 | +615.1% | 265,636 | +571.6% | 0.19% | +603.7% |
| Q1 2016 | $3,752,000 | +117.1% | 39,550 | +112.6% | 0.03% | +125.0% |
| Q4 2015 | $1,728,000 | -94.3% | 18,606 | -94.8% | 0.01% | -93.4% |
| Q3 2015 | $30,287,000 | -8.4% | 355,443 | -8.0% | 0.18% | -17.0% |
| Q2 2015 | $33,078,000 | +244.5% | 386,473 | +241.7% | 0.22% | +282.5% |
| Q1 2015 | $9,601,000 | -52.4% | 113,088 | -51.9% | 0.06% | -42.4% |
| Q4 2014 | $20,153,000 | +24.3% | 235,135 | +10.2% | 0.10% | +4.2% |
| Q3 2014 | $16,219,000 | -14.3% | 213,462 | -11.2% | 0.10% | -13.6% |
| Q2 2014 | $18,934,000 | -60.6% | 240,490 | -62.4% | 0.11% | -47.1% |
| Q1 2014 | $48,003,000 | +68.9% | 640,046 | +73.8% | 0.21% | +76.3% |
| Q4 2013 | $28,428,000 | +61.2% | 368,242 | +44.8% | 0.12% | +63.9% |
| Q3 2013 | $17,632,000 | -53.3% | 254,360 | -57.3% | 0.07% | -61.1% |
| Q2 2013 | $37,746,000 | – | 596,308 | – | 0.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RobecoSam USA, Inc. | 74,961 | $7,572,000 | 9.43% |
| Corvid Peak Capital Management, LLC | 250,000 | $25,250,000 | 8.54% |
| CORTLAND ASSOCIATES INC/MO | 310,508 | $31,361,000 | 6.88% |
| Southpoint Capital Advisors LP | 1,250,000 | $126,250,000 | 6.75% |
| GREEN VALLEY INVESTORS LLC | 2,168,594 | $219,027,000 | 6.70% |
| DAVIS-REA LTD. | 75,080 | $7,595,000 | 5.39% |
| CADINHA & CO LLC | 247,143 | $24,961,000 | 5.35% |
| Espalier Global Management LLC | 47,100 | $4,757,000 | 5.25% |
| Spears Abacus Advisors LLC | 398,334 | $40,232,000 | 5.10% |
| GCA INVESTMENT MANAGEMENT, LLC | 158,064 | $15,964,000 | 5.01% |